Skip to content
  • COMPANY
    • OVERVIEW
    • TOPICA TEAM
  • LULICONAZOLE
    • PRODUCT PROFILE
    • ONYCHOMYCOSIS
  • RESEARCH / TRIALS
    • OVERVIEW
    • PUBLICATIONS
  • INVESTORS
  • NEWS
  • CONTACT

NEWS & VIDEOS

Hot Topics

Topica Presents Promising Luliconazole 10% Solution Data at 2012 AAD Annual Meeting

March 19, 2012

Topica Names Dr. Amir Tavakkol SVP of Clinical Development & Operations

December 5, 2011

A Tribute to Alex Barkas

November 21, 2011

Topica announces completion of $27 million Series B financing

October 18, 2011

Topica announces positive results from Phase 1/2a trial of Luliconazole

June 20, 2011

Topica announces appointment of David E. Cohen, MD, to the Board of Directors

March 28, 2011

Topica announces enrollment of phase 1/2a clinical trial

January 11, 2011

Topica announces sublicensing agreement for tinea pedis indication

September 21, 2010

Disease Overview

Symptoms

Who Gets Onychomycosis

Difficult to Treat

Current Treatments

Unmet Medical Need
and Potential of Luliconazole

©2012 Topica Pharmaceuticals, Inc. All rights reserved.

  • HOME
  • SITE MAP
  • LEGAL
  • CONTACT